Improvement of daptomycin production in streptomyces roseosporus through the acquisition of pleuromutilin resistance

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Li, Linli ^a   Ma, Tingmei ^a   Liu, Qing ^a   Huang, Yuqi ^a   Hu, Changhua ^a   Liao, Guojian ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; GLYCINE; NUCLEAR PROTEIN; PLEUROMUTILIN; RIBOSOME PROTEIN L3; UNCLASSIFIED DRUG; VALINE; DITERPENE; RIBOSOME PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; DRUG MANUFACTURE; GENE LOCUS; GENETIC TRANSCRIPTION; NONHUMAN; POINT MUTATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; STREPTOMYCES; STREPTOMYCES ROSEOSPORUS; WILD TYPE; BIOSYNTHESIS; GENETIC ENGINEERING; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MUTATION; RIBOSOME;

DAPTOMYCIN; DITERPENES; DRUG RESISTANCE, BACTERIAL; GENETIC ENGINEERING; MUTATION; RIBOSOMAL PROTEINS; RIBOSOMES; STREPTOMYCES;

EID: 84884863304     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/479742     Document Type: Article

References (24)

1. Arbeit R. D., Maki D., Tally F. P., Campanaro E., Eisenstein B. I., The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clinical Infectious Diseases 2004 38 12 1673 1681 2-s2.0-2942665465 10.1086/420818 (Pubitemid 38781657)
2. Fowler V. G. Jr., Boucher H. W., Corey G. R., Abrutyn E., Karchmer A. W., Rupp M. E., Levine D. P., Chambers H. F., Tally F. P., Vigliani G. A., Cabell C. H., Link A. S., DeMeyer I., Filler S. G., Zervos M., Cook P., Parsonnet J., Bernstein J. M., Price C. S., Forrest G. N., Fätkenheuer G., Gareca M., Rehm S. J., Brodt H. R., Tice A., Cosgrove S. E., Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. The New England Journal of Medicine 2006 355 7 653 665 2-s2.0-33747365321 10.1056/NEJMoa053783
3. Iiao G., Shi T., Xie J., Regulation mechanisms underlying the biosynthesis of daptomycin and related lipopeptides. Journal of Cellular Biochemistry 2012 113 3 735 741 2-s2.0-84857522790 10.1002/jcb.23414
4. Yu G., Jia X., Wen J., Lu W., Wang G., Caiyin Q., Chen Y., Strain improvement of Streptomyces roseosporus for daptomycin production by rational screening of He-Ne laser and NTG induced mutants and kinetic modeling. Applied Biochemistry and Biotechnology 2011 163 6 729 743 2-s2.0-79952704190 10.1007/s12010-010-9078-x
5. Liao G., Wang L., Liu Q., Guan F., Huang Y., Hu C., Manipulation of kynurenine pathway for enhanced daptomycin production in Streptomyces roseosporus. Biotechnology Progress 2013 10.1002/btpr.1740
6. Huang D., Wen J., Wang G., Yu G., Jia X., Chen Y., In silico aided metabolic engineering of Streptomyces roseosporus for daptomycin yield improvement. Applied Microbiology and Biotechnology 2012 94 3 637 649 2-s2.0-84857827342 10.1007/s00253-011-3773-6
7. Huang D., Jia X., Wen J., Wang G., Yu G., Caiyin Q., Chen Y., Metabolic flux analysis and principal nodes identification for daptomycin production improvement by Streptomyces roseosporus. Applied Biochemistry and Biotechnology 2011 165 7-8 1725 1739 2-s2.0-81955167921 10.1007/s12010-011-9390-0
8. Ochi K., Hosaka T., New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters. Applied Microbiology and Biotechnology 2013 97 1 87 98 10.1007/s00253-012-4551-9
9. Wang G., Hosaka T., Ochi K., Dramatic activation of antibiotic production in Streptomyces coelicolor by cumulative drug resistance mutations. Applied and Environmental Microbiology 2008 74 9 2834 2840 2-s2.0-43049129603 10.1128/AEM.02800-07 (Pubitemid 351632614)
10. Kurosawa K., Hosaka T., Tamehiro N., Inaoka T., Ochi K., Improvement of α -amylase production by modulation of ribosomal component protein S12 in Bacillus subtilis 168. Applied and Environmental Microbiology 2006 72 1 71 77 2-s2.0-33644848909 10.1128/AEM.72.1.71-77.2006
11. Ochi K., Okamoto S., Tozawa Y., Inaoka T., Hosaka T., Xu J., Kurosawa K., Ribosome engineering and secondary metabolite production. Advances in Applied Microbiology 2004 56 155 184 2-s2.0-9644275536 10.1016/S0065-2164(04)56005-7 (Pubitemid 39574534)
12. Tanaka Y., Kasahara K., Hirose Y., Murakami K., Kugimiya R., Ochi K., Activation and products of the cryptic secondary metabolite biosynthetic gene clusters by rifampin resistance (rpoB) mutations in actinomycetes. Journal of Bacteriology 2013 195 13 2959 2970 10.1128/JB.00147-13
13. Wang L., Zhao Y., Liu Q., Huang Y., Hu C., Liao G., Improvement of A21978C production in Streptomyces roseosporus by reporter-guided rpsL mutation selection. Journal of Applied Microbiology 2012 112 6 1095 1101 2-s2.0-84860289948 10.1111/j.1365-2672.2012.05302.x
14. Hu C., Zou Y., Mutilins derivatives: from veterinary to human-used antibiotics. Mini-Reviews in Medicinal Chemistry 2009 9 12 1397 1406 2-s2.0-74049156420 10.2174/138955709789957387
15. Malbruny B., Werno A. M., Murdoch D. R., Leclercq R., Cattoir V., Cross-resistance to lincosamides, streptogramins A, and pleuromutilins due to the lsa (C) gene in Streptococcus agalactiae UCN70. Antimicrobial Agents and Chemotherapy 2011 55 4 1470 1474 2-s2.0-79953221474 10.1128/AAC.01068-10
16. Li B. B., Wu C. M., Wang Y., Shen J. Z., Single and dual mutations at positions 2058, 2503 and 2504 of 23s rRNA and their relationship to resistance to antibiotics that target the large ribosomal subunit. Journal of Antimicrobial Chemotherapy 2011 66 9 1983 1986 2-s2.0-80051689000 10.1093/jac/dkr268
17. Gentry D. R., Rittenhouse S. F., McCloskey L., Holmes D. J., Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrobial Agents and Chemotherapy 2007 51 6 2048 2052 2-s2.0-34250186772 10.1128/AAC.01066-06 (Pubitemid 46903093)
18. Pringle M., Poehlsgaard J., Vester B., Long K. S., Mutations in ribosomal protein L3 and 23S ribosomal RNA at the peptidyl transferase centre are associated with reduced susceptibility to tiamulin in Brachyspira spp. isolates. Molecular Microbiology 2004 54 5 1295 1306 2-s2.0-9644301282 10.1111/j.1365-2958.2004.04373.x (Pubitemid 39578272)
19. Nguyen K. T., Kau D., Gu J. Q., Brian P., Wrigley S. K., Baltz R. H., Miao V., A glutamic acid 3-methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus. Molecular Microbiology 2006 61 5 1294 1307 2-s2.0-33747056235 10.1111/j.1365-2958.2006. 05305.x (Pubitemid 44215428)
20. Wang L., Tian X., Wang J., Yang H., Fan K., Xu G., Yang K., Tan H., Autoregulation of antibiotic biosynthesis by binding of the end product to an atypical response regulator. Proceedings of the National Academy of Sciences of the United States of America 2009 106 21 8617 8622 2-s2.0-66649105444 10.1073/pnas.0900592106
21. Pan Y., Liu G., Yang H., Tian Y., Tan H., The pleiotropic regulator AdpA-L directly controls the pathway-specific activator of nikkomycin biosynthesis in Streptomyces ansochromogenes. Molecular Microbiology 2009 72 3 710 723 2-s2.0-65349122992 10.1111/j.1365-2958.2009.06681.x
22. Miao V., Coeffet-Legal M. F., Brian P., Brost R., Penn J., Whiting A., Martin S., Ford R., Parr I., Bouchard M., Silva C. J., Wrigley S. K., Baltz R. H., Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology 2005 151 5 1507 1523 2-s2.0-21044448952 10.1099/mic.0.27757-0 (Pubitemid 40711798)
23. Ochi K., From microbial differentiation to ribosome engineering. Bioscience, Biotechnology and Biochemistry 2007 71 6 1373 1386 2-s2.0-34347344063 10.1271/bbb.70007 (Pubitemid 47012008)
24. Novak R., Are pleuromutilin antibiotics finally fit for human use? Annals of the New York Academy of Sciences 2011 1241 1 71 81 2-s2.0-84255209192 10.1111/j.1749-6632.2011.06219.x